Azitra Inc (AZTR)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $3.80M
Last updated: Nov 17, 2026 at 4:31 PM ET
Azitra Inc (AZTR) Statistics
Azitra (AZTR) has a market cap of $3.80M and an enterprise value of $49.19K. Its share count is up 2401.77% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 98.71% below the market cap, as cash exceeds debt.
| Market Cap | $3.80M |
|---|---|
| Enterprise Value | $49.19K |
| Latest price (Nov 17, 2026) | $0.61 |
Key Dates
| Last Earnings Date | Nov 12, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 1.4x |
|---|---|
| P/TBV Ratio | 1.5x |
Price Statistics
The stock is down 83.27% over 52 weeks and trades 46.49% below its 50-day average.
| Beta (1Y) | 0.19 |
|---|---|
| 52-Week Change | -83.27% |
| 1-Month Change | -14.84% |
| 3-Month Change | -51.37% |
| 6-Month Change | -67.95% |
| Total Return (1Y) | -83.27% |
| Total Return (3Y CAGR) | -94.20% |
| Max Drawdown (1Y) | -84.76% |
| Max Drawdown (3Y) | -99.99% |
| Sharpe Ratio (1Y) | -1.17 |
| Correlation with SPY (1Y) | 0.02 |
| 50-Day Average | $1.14 |
| 200-Day Average | $1.70 |
| 52-Week Range | $0.52 to $3.91 |
| RSI (14 Days) | 39.0 |
| Average Volume (20 Days) | 7.93M |
Financial Position
Current assets cover 3.11x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 3.11x |
|---|---|
| Quick Ratio | 3.11x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -283.30% and return on assets is -208.55% over the last 12 months.
| Return on Equity (ROE) | -283.30% |
|---|---|
| Return on Assets (ROA) | -208.55% |
Scores
AZTR has a Piotroski F-Score of 0 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 0 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$113.10K |
| Operating Income | -$12.49M |
| Pretax Income | -$12.45M |
| Net Income | -$12.46M |
| EBITDA | -$12.14M |
| Reported EPS (TTM) | -$4.13 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 73.70% of the $5.97M in total assets.
| Cash and Equivalents | $3.75M |
|---|---|
| Total Debt | $0 |
| Net Cash | $3.75M |
| Net Cash Per Share | $0.36 |
| Working Capital | $3.25M |
| Shareholder Equity | $4.40M |
| Book Value Per Share | $0.43 |
| Tangible Book Value | $4.17M |
| Tangible Book Per Share | $0.40 |
| Total Assets | $5.97M |
| Total Liabilities | $1.58M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $82.62K of capital spending, operating cash flow left -$11.65M of free cash flow.
| Operating Cash Flow | -$11.56M |
|---|---|
| Capital Expenditures | $82.62K |
| Free Cash Flow | -$11.65M |
| FCF Per Share | -$1.92 |
| Depreciation and Amortization | $451.94K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | -30.29% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -30.70% |
Dividends and Yields
AZTR does not pay a dividend. Its free cash flow yield is -185.66%.
| FCF Yield | -185.66% |
|---|---|
| Buyback Yield | -228.57% |
| Shareholder Yield | -228.57% |
Stock Splits
The last split was a 1-for-10 reverse split on Oct 26, 2026.
| Last Split Date | Oct 26, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About AZTR
What is AZTR's market cap?
Azitra has a market cap of $3.80M. Its enterprise value, which adds debt and subtracts cash, is $49.19K.
How many shares of AZTR are outstanding?
Azitra has 10.30M shares outstanding. The count is up 2401.77% from a year earlier.
Does AZTR pay a dividend?
No. Azitra does not pay a dividend.
How much debt does AZTR have?
Azitra has $0 of total debt and $3.75M of cash and equivalents, a net cash position of $3.75M.
AZTR pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors